Ladone Mary Kay
- SEC CIK
- 0001760737
In the past year, 1 open-market sale filing worth $98.5K and no purchases.
Current role at each company
- KMTS Kestra Medical Technologies, Ltd.Directoras of Sep 10, 2026
- INGN Inogen IncDirectoras of Jun 9, 2026
- BVS Bioventus Inc.Directoras of Jun 4, 2026
- NOVT Novanta IncDirectoras of Jan 6, 2026
- HRC Hill-Rom Holdings, Inc.SVP, Corp. Dev., Strat. & IRas of Dec 15, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $98.5K
- 1 filing
- Net
- −$98.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Ladone Mary Kay as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KMTS Kestra Medical Technologies, Ltd.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 (view filing)8:25 PM ET | Sep 8 | 2 days | Ladone Mary KayDirector | SSale | −3.91K | $25.20 | −$98.5K | −9.4%37.5K after |
HRC Hill-Rom Holdings, Inc.
SVP, Corp. Dev., Strat. & IR4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2021 (view filing) | Nov 11 | 1 day | Ladone Mary KaySVP, Corp. Dev., Strat. & IR | SSale | −2.02K | $155.14 | −$313.1K | −52.3%1.84K after | |
| Nov 10, 2021 (view filing) | Nov 8 | 2 days | Ladone Mary KaySVP, Corp. Dev., Strat. & IR | SSale | −2.92K | $155.08 | −$453.3K | −100.0%0 after | 2 lots |
| Jul 30, 2021 (view filing) | Jul 28 | 2 days | Ladone Mary KaySVP, Corp. Dev., Strat. & IR | SSale | −9.06K | $127.62 | −$1.16M | −100.0%0 after | 4 lots |
| Jul 27, 2021 (view filing) | Jul 23 | 4 days | Ladone Mary KaySVP, Corp. Dev., Strat. & IR | SSale | −8.35K | $120.00 | −$1.00M | −59.4%5.70K after | 3 lots |